Company profile BTTX
After 92 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 0 days it will total up to 0.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 87 |
| 2019 | 52 -40.2% QoQ | 52 0.0% QoQ | 41 -21.2% QoQ | 117 34.5% YoY 185.4% QoQ |
| 2020 | 29 -44.2% YoY -75.2% QoQ | 38 -26.9% YoY 31.0% QoQ | 89 117.1% YoY 134.2% QoQ | 88 -24.8% YoY -1.1% QoQ |
| 2021 | 57 96.6% YoY -35.2% QoQ | 125 228.9% YoY 119.3% QoQ | 103 15.7% YoY -17.6% QoQ | 162 84.1% YoY 57.3% QoQ |
| 2022 | 53 -7.0% YoY -67.3% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ |
| 2023 | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ |
The average 5 years interest of Better Therapeutics was 4.2 per week. The last year interest of Better Therapeutics compared to the last 5 years has changed by -100.0%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -100.0%.
There is not enough data for BT-001 diabetes treatment to provide analysis
There is not enough data for BT-001 diabetes treatment to provide correlation calculation
There is not enough data for BT-001 diabetes treatment to provide analysis
After 39 days of this quarter the interest is at 154.0. Based on that we can calculate that during remaining 52 days it will total up to 359.0. Prescription digital therapeutics expected interest is significantly higher compared to previous quarter (+452.3%) and same quarter last year (+498.3%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 0 | 80 inf% QoQ | 34 -57.5% QoQ | 26 -23.5% QoQ |
| 2020 | 37 inf% YoY 42.3% QoQ | 0 -100.0% YoY -100.0% QoQ | 46 35.3% YoY inf% QoQ | 94 261.5% YoY 104.3% QoQ |
| 2021 | 26 -29.7% YoY -72.3% QoQ | 49 inf% YoY 88.5% QoQ | 59 28.3% YoY 20.4% QoQ | 67 -28.7% YoY 13.6% QoQ |
| 2022 | 86 230.8% YoY 28.4% QoQ | 64 30.6% YoY -25.6% QoQ | 0 -100.0% YoY -100.0% QoQ | 122 82.1% YoY inf% QoQ |
| 2023 | 60 -30.2% YoY -50.8% QoQ | 77 20.3% YoY 28.3% QoQ | 96 inf% YoY 24.7% QoQ | 65 -46.7% YoY -32.3% QoQ |
| 2024 | 154 156.7% YoY 136.9% QoQ | - | - | - |
The average 5 years interest of Prescription digital therapeutics was 4.76 per week. The last year interest of Prescription digital therapeutics compared to the last 5 years has changed by 76.89%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 213.01%.
There is not enough data for Cardiometabolic diseases treatment to provide analysis
There is not enough data for Cardiometabolic diseases treatment to provide correlation calculation
There is not enough data for Cardiometabolic diseases treatment to provide analysis
After 39 days of this quarter the interest is at 204.0. Based on that we can calculate that during remaining 52 days it will total up to 476.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 317 | 335 5.7% QoQ | 356 6.3% QoQ | 307 -13.8% QoQ |
| 2020 | 452 42.6% YoY 47.2% QoQ | 431 28.7% YoY -4.6% QoQ | 288 -19.1% YoY -33.2% QoQ | 440 43.3% YoY 52.8% QoQ |
| 2021 | 415 -8.2% YoY -5.7% QoQ | 406 -5.8% YoY -2.2% QoQ | 324 12.5% YoY -20.2% QoQ | 430 -2.3% YoY 32.7% QoQ |
| 2022 | 607 46.3% YoY 41.2% QoQ | 568 39.9% YoY -6.4% QoQ | 378 16.7% YoY -33.5% QoQ | 512 19.1% YoY 35.4% QoQ |
| 2023 | 629 3.6% YoY 22.9% QoQ | 512 -9.9% YoY -18.6% QoQ | 448 18.5% YoY -12.5% QoQ | 618 20.7% YoY 37.9% QoQ |
| 2024 | 204 -67.6% YoY -67.0% QoQ | - | - | - |
The average 5 years interest of Type 2 diabetes therapy was 34.39 per week. The last year interest of Type 2 diabetes therapy compared to the last 5 years has changed by 19.4%. The interest for Type 2 diabetes therapy is trending. The last year interest is quite higher compared to 5 years ago. It has increased by 47.43%.
After 39 days of this quarter the interest is at 373.0. Based on that we can calculate that during remaining 52 days it will total up to 870.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 486 | 659 35.6% QoQ | 564 -14.4% QoQ | 595 5.5% QoQ |
| 2020 | 708 45.7% YoY 19.0% QoQ | 683 3.6% YoY -3.5% QoQ | 580 2.8% YoY -15.1% QoQ | 679 14.1% YoY 17.1% QoQ |
| 2021 | 601 -15.1% YoY -11.5% QoQ | 642 -6.0% YoY 6.8% QoQ | 537 -7.4% YoY -16.4% QoQ | 591 -13.0% YoY 10.1% QoQ |
| 2022 | 821 36.6% YoY 38.9% QoQ | 860 34.0% YoY 4.8% QoQ | 731 36.1% YoY -15.0% QoQ | 844 42.8% YoY 15.5% QoQ |
| 2023 | 922 12.3% YoY 9.2% QoQ | 949 10.3% YoY 2.9% QoQ | 811 10.9% YoY -14.5% QoQ | 1035 22.6% YoY 27.6% QoQ |
| 2024 | 373 -59.5% YoY -64.0% QoQ | - | - | - |
The average 5 years interest of Heart disease treatment was 56.21 per week. The last year interest of Heart disease treatment compared to the last 5 years has changed by 26.61%. The interest for Heart disease treatment is trending. The last year interest is quite higher compared to 5 years ago. It has increased by 44.33%.
There is not enough data for Digital therapeutics software to provide analysis
There is not enough data for Digital therapeutics software to provide correlation calculation
There is not enough data for Digital therapeutics software to provide analysis
There is not enough data for Better Therapeutics jobs to provide analysis
There is not enough data for Better Therapeutics jobs to provide correlation calculation
There is not enough data for Better Therapeutics jobs to provide analysis
There is not enough data for Better Therapeutics reviews to provide analysis
There is not enough data for Better Therapeutics reviews to provide correlation calculation
There is not enough data for Better Therapeutics reviews to provide analysis
There is not enough data for Better Therapeutics San Francisco to provide analysis
There is not enough data for Better Therapeutics San Francisco to provide correlation calculation
There is not enough data for Better Therapeutics San Francisco to provide analysis